文献速递脑血管病

超声增强溶栓治疗大血管闭塞急性缺血性卒中:个体患者数据荟萃分析

Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis.
PubMed 文献 · Stroke · 2021-08-25

该个体患者数据荟萃分析纳入7项随机对照试验共1102例急性缺血性卒中患者,其中138例和134例确认大血管闭塞者分别接受超声增强溶栓联合或不联合微球治疗与单纯静脉溶栓。结果显示超声增强溶栓组完全再通率显著高于对照组(40.3% vs 22.4%;OR 2.17,95%CI 1.03-4.54),症状性颅内出血风险无显著差异。

要点

  • 超声增强溶栓使大血管闭塞患者完全再通 odds 提高约2倍(OR 2.17)。
  • 症状性颅内出血风险两组无显著差异(7.3% vs 3.7%;OR 2.03)。
  • 3个月功能预后及无症状性颅内出血未见差异。

核心结论

  • 在大血管闭塞的急性缺血性卒中患者中,超声增强溶栓与完全再通 odds 提高近2倍相关,安全性和有效性需进一步研究。

研究设计与样本

  • 个体患者数据荟萃分析,纳入7项随机对照试验,共1102例急性缺血性卒中患者,其中138例和134例确认大血管闭塞者分别随机分配至治疗组和对照组。

主要发现

  • 超声增强溶栓组完全再通率为40.3%,对照组为22.4%(OR 2.17,95%CI 1.03-4.54;调整OR 2.33,95%CI 1.02-5.34)。
  • 症状性颅内出血发生率治疗组7.3%,对照组3.7%(OR 2.03,95%CI 0.68-6.11;调整OR 2.55,95%CI 0.76-8.52),无显著差异。
  • 无症状性颅内出血、3个月良好功能预后及3个月功能独立两组均无差异。

关键数值与推荐

  • 主要结局为静脉溶栓开始后1至36小时内完全再通率。
  • 调整变量包括年龄、性别、基线卒中严重程度、收缩压和发病至治疗时间。

临床怎么用

  • 对于大血管闭塞的急性缺血性卒中患者,超声增强溶栓可能提高完全再通率,但需权衡症状性颅内出血风险并进一步验证。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Evidence about the utility of ultrasound-enhanced thrombolysis (sonothrombolysis) in patients with acute ischemic stroke (AIS) is conflicting. We aimed to evaluate the safety and efficacy of sonothrombolysis in patients with AIS with large vessel occlusion, by analyzing individual patient data of available randomized-controlled clinical trials. METHODS: We included all available randomized-controlled clinical trials comparing sonothrombolysis with or without addition of microspheres (treatment group) to intravenous thrombolysis alone (control group) in patients with AIS with large vessel occlusion. The primary outcome measure was the rate of complete recanalization at 1 to 36 hours following intravenous thrombolysis initiation. We present crude odds ratios (ORs) and ORs adjusted for the predefined variables of age, sex, baseline stroke severity, systolic blood pressure, and onset-to-treatment time. RESULTS: We included 7 randomized controlled clinical trials that enrolled 1102 patients with AIS. A total of 138 and 134 confirmed large vessel occlusion patients were randomized to treatment and control groups respectively. Patients randomized to sonothrombolysis had increased odds of complete recanalization compared with patients receiving intravenous thrombolysis alone (40.3% versus 22.4%; OR, 2.17 [95% CI, 1.03-4.54]; adjusted OR, 2.33 [95% CI, 1.02-5.34]). The likelihood of symptomatic intracranial hemorrhage was not significantly different between the 2 groups (7.3% versus 3.7%; OR, 2.03 [95% CI, 0.68-6.11]; adjusted OR, 2.55 [95% CI, 0.76-8.52]). No differences in the likelihood of asymptomatic intracranial hemorrhage, 3-month favorable functional and 3-month functional independence were documented. CONCLUSIONS: Sonothrombolysis was associated with a nearly 2-fold increase in the odds of complete recanalization compared with intravenous thrombolysis alone in patients with AIS with large vessel occlusions. Further study of the safety and efficacy of sonothrombolysis is warranted.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tsivgoulis G, Katsanos AH, Eggers J, et al. Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis. Stroke. 2021. PMID: 34428930. doi:10.1161/STROKEAHA.120.030960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。